Importance of antithrombin therapy during coronary angioplasty
- 31 May 1991
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (6), 96-100
- https://doi.org/10.1016/0735-1097(91)90944-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferationJournal of the American College of Cardiology, 1990
- Effect of balloon inflation on smooth muscle cell proliferation in the porcine carotid arteryJournal of the American College of Cardiology, 1990
- Three days of heparin pretreatment reduces major complications of coronary angioplasty in patients with unstable anginaJournal of the American College of Cardiology, 1990
- Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.Journal of Clinical Investigation, 1990
- Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.Journal of Clinical Investigation, 1989
- Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1989
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1985
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984